Related Experiment Video
Updated: Jul 26, 2026
10:55
Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging
Published on: January 5, 2015
Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics
S E Seltzer1, M Blau, L W Herman
1Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115.
Radiology
|March 1, 1995
Summary
Interdigitation-fusion (IF) liposomes carrying iotrolan show promising biodistribution and clearance for use as hepatosplenic contrast agents in CT imaging.
Area of Science:
- Nanomedicine
- Radiology
- Biotechnology
Background:
- Liposomes are widely used as drug delivery vehicles.
- Iotrolan is a non-ionic contrast agent used in computed tomography (CT).
- Developing effective and safe contrast agents is crucial for diagnostic imaging.
Purpose of the Study:
- To evaluate the biodistribution, clearance, and CT imaging properties of interdigitation-fusion (IF) liposomes loaded with iotrolan.
- To assess the potential of these IF liposomes as hepatosplenic contrast agents.
Main Methods:
- IF liposomes containing iotrolan were prepared.
- Biodistribution and clearance were studied in rats.
- CT scans were performed on rats and dogs after administration of IF liposomes at varying iodine doses.
Main Results:
- High initial uptake of IF liposomes was observed in the liver and spleen (63%-96%).
- Liver elimination half-lives ranged from 8.7 to 12.9 days, depending on the iodine dose.
- Significant hepatic and splenic enhancement was noted in CT scans of both rats and dogs.
Conclusions:
- IF liposomes demonstrate favorable biodistribution and clearance profiles.
- These liposomes exhibit suitable imaging characteristics for hepatosplenic contrast enhancement.
- IF liposomes represent a promising option for developing advanced CT contrast agents.
